Giorgio Dini
Overview
Explore the profile of Giorgio Dini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1804
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rabusin M, Snowden J, Veys P, Quartier P, Dalle J, Dhooge C, et al.
Biol Blood Marrow Transplant
. 2012 Dec;
19(4):666-9.
PMID: 23253561
We analyzed the long-term outcomes of pediatric patients registered in the European Group for Blood and Marrow Transplantation database who underwent hematopoietic stem cell transplantation (HSCT) for severe treatment refractory...
2.
Faraci M, Caviglia I, Biral E, Morreale G, Giardino S, Garbarino L, et al.
Pediatr Transplant
. 2012 Nov;
16(8):887-93.
PMID: 23131057
a-GvHD may complicate allogeneic HSCT. In this retrospective single-center study, we evaluated incidence and risk factors of a-GvHD in 197 consecutive allogeneic pediatric HSCTs applying Glucksberg and NIH a-GvHD classifications....
3.
Corbacioglu S, Cesaro S, Faraci M, Valteau-Couanet D, Gruhn B, Rovelli A, et al.
Lancet
. 2012 Feb;
379(9823):1301-9.
PMID: 22364685
Background: Hepatic veno-occlusive disease is a leading cause of morbidity and mortality after haemopoietic stem-cell transplantation (HSCT). We aimed to assess whether defibrotide can reduce the incidence of veno-occlusive disease...
4.
Styczynski J, Balduzzi A, Gil L, Labopin M, Hamladji R, Marktel S, et al.
Blood
. 2011 Dec;
119(12):2935-42.
PMID: 22160619
We investigated prospectively factors influencing the safety of hematopoietic stem cell (HSC) collection in 453 pediatric donors. The children in the study donated either BM or peripheral blood stem cells...
5.
Dini G, Zecca M, Balduzzi A, Messina C, Masetti R, Fagioli F, et al.
Blood
. 2011 Oct;
118(25):6683-90.
PMID: 22010101
Acute lymphoblastic leukemia (ALL) in second complete remission is one of the most common indications for allogeneic hematopoietic stem cell transplantation (HSCT) in pediatric patients. We compared the outcome after...
6.
Rondelli R, Dini G, De Rosa M, Quarello P, Bisogno G, Arico M, et al.
Ital J Pediatr
. 2011 Sep;
37:44.
PMID: 21923939
Background: There has been a noticeable annual increase in the number of children coming to Italy for medical treatment, just like it has happened in the rest of the European...
7.
Ferrari A, Arico M, Dini G, Rondelli R, Porta F
Pediatr Hematol Oncol
. 2011 Jun;
29(1):55-61.
PMID: 21707221
A limited proportion of adolescents with cancer currently receives treatment at pediatric oncology centers and this factor is considered one of the possible explanations for the lack of improvement in...
8.
Klingebiel T, Cornish J, Labopin M, Locatelli F, Darbyshire P, Handgretinger R, et al.
Blood
. 2009 Dec;
115(17):3437-46.
PMID: 20040760
T cell-depleted haploidentical hematopoietic stem cell transplantation (haploHSCT) is an option to treat children with very high-risk acute lymphoblastic leukemia (ALL) lacking an HLA-identical donor. We analyzed 127 children with...
9.
Schmitz N, Sureda A, Dini G, Claviez A
Blood
. 2009 Dec;
114(20):4605-6.
PMID: 19965711
No abstract available.
10.
Faraci M, Bagnasco F, Corti P, Messina C, Fagioli F, Podda M, et al.
Biol Blood Marrow Transplant
. 2009 Sep;
15(10):1271-6.
PMID: 19747635
A retrospective study was conducted among Italian children treated with hematopoietic stem cell transplant (HSCT) to evaluate the incidence and risk factors in the development of osteochondroma (OC). OC occurred...